Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPI-1005 in Meniere's Disease
NCT02603081Phase 2Completed
- Sponsor
- Sound Pharmaceuticals
- Start
- Dec 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ebselen in Meniere's disease (MD), sponsored by Sound Pharmaceuticals. Started Dec 2015; status: completed.
02
Drugs
ebselen
03
Conditions
Meniere's disease (MD)
Beyond the preview
Go deeper on NCT02603081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603081.